ASC
NVAX icon

Ares Systematic Credit’s Novavax NVAX Stock Holding History

Ares Systematic Credit’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$755K Sell
80,155
-9,382
-10% -$84.1K 0.46% 69
2026
Q1 		$724K Sell
89,537
-22,850
-20% -$207K 0.57% 49
2025
Q4 		$755K Buy
+112,387
New +$847K 0.61% 48

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Ares Systematic Credit's NVAX Position: Q2 2026 in Review

Ares Systematic Credit reduced its Novavax (NVAX) stake by 10% in Q2 2026, selling an estimated $84.1K and leaving 80,155 shares worth $755K. The position accounts for 0.46% of the portfolio, ranked #69.

Ares Systematic Credit first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $755K in Q4 2025. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Ares Systematic Credit held 80,155 shares of Novavax worth $755K as of Q2 2026.
  • Ares Systematic Credit sold 9,382 Novavax shares in Q2 2026, an estimated $84.1K.
  • Novavax made up 0.46% of Ares Systematic Credit's portfolio in Q2 2026, its #69 holding.
  • Ares Systematic Credit first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
  • Ares Systematic Credit's Novavax position peaked at $755K in Q4 2025.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Ares Systematic Credit's 13F filing for Q2 2026, filed 14 Aug 2026.